Recent Updates
Recently added Catalysts
RARE

Ultragenyx Gains Worldwide Rights to Triheptanoin (UX007)

Thursday, July 11, 2013 1 min read
Key Takeaway: Ultragenyx Gains Worldwide Rights to Triheptanoin (UX007)

Full Press Release Details

Ultragenyx Gains Worldwide Rights to Triheptanoin (UX007).
Tags: RARE Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jul 11, 2013